# Trial of Oral Melatonin in Elevated Blood Pressure

Study · id `cardio:ct-nct03764020` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03764020](<https://clinicaltrials.gov/study/NCT03764020>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03764020

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 320 participants.

## Technical summary

Registry record NCT03764020. Randomized; triple masking; primary purpose treatment. Start 2019-06-01 (anticipated); primary completion 2019-11-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 320 participants (planned count; ClinicalTrials.gov record NCT03764020, source copy `cardio:ctgov-nct03764020-2019-04-10`, retrieved 2026-10-26)
- Planned start: 2019-06-01 (anticipated) (ClinicalTrials.gov record NCT03764020, source copy `cardio:ctgov-nct03764020-2019-04-10`, retrieved 2026-10-26)
- Primary completion: 2019-11-01 (anticipated) (ClinicalTrials.gov record NCT03764020, source copy `cardio:ctgov-nct03764020-2019-04-10`, retrieved 2026-10-26)
- Completion: 2019-12-01 (anticipated) (ClinicalTrials.gov record NCT03764020, source copy `cardio:ctgov-nct03764020-2019-04-10`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03764020-2019-04-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: Trial of Oral Melatonin in Elevated Blood Pressure
- Acronym: MRCTEBP
- Condition: Elevated Blood Pressure
- Intervention (Drug): Placebo oral capsule/placebo comparator
- Intervention (Drug): Melatonin/experimental
- Lead sponsor: Tehran University of Medical Sciences
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Tehran University of Medical Sciences (`cardio:org-tehran-university-of-medical-sciences`)

## Provenance

Content hash: 753ae7cd8258a8b131b100af2fb5d24c53fd1ec8be769823862b620363a85265
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
